Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dalton

Showing results (51-60 of 375) with videos related to

Pageof 38
Sort By:
British Journal of Haematology|February 1, 1988
Reversal of drug-resistance in multiple myeloma with verapamilB G Durie, W S Dalton
Hematology/Oncology Clinics of North America|April 1, 1992
Drug resistance in myeloma: mechanisms and approaches to circumventionW S Dalton, S E Salmon
Science (New York, N.Y.)|May 27, 2006
Cancer biomarkers--an invitation to the tableWilliam S Dalton, Stephen H Friend
Oncology (Williston Park, N.Y.)|February 24, 2001
Considerations in the management of myelomaM N Fishman, W S Dalton
Journal of the National Cancer Institute|October 8, 1999
Lung resistance-related protein: determining its role in multidrug resistanceW S Dalton, R J Scheper
Cancer Metastasis Reviews|February 8, 2002
Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignanciesL A Hazlehurst, W S Dalton
Journal of the American Podiatric Medical Association|March 30, 1999
Contact coral dermatitis affecting the ankleS Dalton, J Pontious, H Lemont
The Medical Journal of Australia|July 1, 2009
Patients expect transparency in doctors' relationships with the pharmaceutical industry. CommentBrad S Dalton, Deborah J Richards
Cancer Metastasis Reviews|December 1, 1996
Multiple drug resistance and intermediate filamentsA E Cress, W S Dalton
The Journal of Rheumatology. Supplement|March 1, 1996
Relevance of multidrug resistance to rheumatoid arthritis: development of a new therapeutic hypothesisS E Salmon, W S Dalton
Pageof 38

Showing results (51-60 of 375) with videos related to

Sort By:
Pageof 38
British Journal of Haematology|February 1, 1988
Reversal of drug-resistance in multiple myeloma with verapamilB G Durie, W S Dalton
Hematology/Oncology Clinics of North America|April 1, 1992
Drug resistance in myeloma: mechanisms and approaches to circumventionW S Dalton, S E Salmon
Science (New York, N.Y.)|May 27, 2006
Cancer biomarkers--an invitation to the tableWilliam S Dalton, Stephen H Friend
Oncology (Williston Park, N.Y.)|February 24, 2001
Considerations in the management of myelomaM N Fishman, W S Dalton
Journal of the National Cancer Institute|October 8, 1999
Lung resistance-related protein: determining its role in multidrug resistanceW S Dalton, R J Scheper
Cancer Metastasis Reviews|February 8, 2002
Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignanciesL A Hazlehurst, W S Dalton
Journal of the American Podiatric Medical Association|March 30, 1999
Contact coral dermatitis affecting the ankleS Dalton, J Pontious, H Lemont
The Medical Journal of Australia|July 1, 2009
Patients expect transparency in doctors' relationships with the pharmaceutical industry. CommentBrad S Dalton, Deborah J Richards
Cancer Metastasis Reviews|December 1, 1996
Multiple drug resistance and intermediate filamentsA E Cress, W S Dalton
The Journal of Rheumatology. Supplement|March 1, 1996
Relevance of multidrug resistance to rheumatoid arthritis: development of a new therapeutic hypothesisS E Salmon, W S Dalton
Pageof 38